Share this article
Share this article
SEATTLE, May 19, 2021 /PRNewswire/ OnQuality Pharmaceuticals ( OnQuality ), a targeted cancer supportive care company developing medications to address specific side effects and improve the quality of life for patients receiving anti-cancer medications, today announced that abstracts for the NOVA-II clinical trial evaluating OnQuality s lead candidate, OQL011, have been selected for presentations at two upcoming meetings: a Trial in Progress poster presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting, being held virtually from June 4-8, 2021, and an oral presentation at the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO) Annual Meeting, being held virtually from June 24-26, 2021. The abstracts for both presentations include an update on the ongoing Phase II clinical trial and are both titled A Study to Investigate OQL011 on VEGFR Inhibitor-Associated
OnQuality Pharmaceuticals to Present on NOVA-II Trial Evaluating OQL011 at the 2021 ASCO and MASCC/ISOO Annual Meetings
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
04.14.21 Advice For Aspiring Biopharma CEOs
State-of-the-art continuous manufacturing technologies are being developed and implemented to manufacture a wide variety of products. Several vendors offer development-scale to commercial-scale continuous downstream chromatography systems. When adopting continuous technology, it is critical to demonstrate that continuous downstream processes are comparable to batch-mode downstream processes and provide the supporting comparability data for technical and business decisions.
Access the case study to learn more.
Featured Articles
In my experience, the most effective leaders are intentional about everything they do: how they speak, how they listen, the everyday conduct of their lives.
Video
Michael McCullar, Ph.D., CEO of OnQuality Pharmaceuticals, kicks off this executive virtual roundtable segment by discussing some of the challenges around diversity and inclusion (D&I) during M&A tran
On Tuesday morning, Comal Independent School District trustees will meet to approve winter weather class waivers as the first students return to Specht Elementary School, flooded by burst water pipes a few weeks ago.
âThe whole front office was flooded along with several classrooms,â Steve Stanford, the districtâs communications director said  of the damage at the school, which will welcome back kindergartners and first-grade students. âWe were able to mitigate damages enough to bring some of those young kids back on Tuesday.â
Comal ISDâs School Operations group posted photographs from Specht Elementary School on Twitter over the weekend. Water lines in the ceiling burst as part of last weekâs winter storm.
vimarsana © 2020. All Rights Reserved.